Tianjin Chase Sun Pharmaceutical Co.,Ltd

SZSE:300026 Lagerbericht

Marktkapitalisierung: CN¥12.4b

Tianjin Chase Sun PharmaceuticalLtd Management

Management Kriterienprüfungen 3/4

Tianjin Chase Sun PharmaceuticalLtd's CEO is Dan Zheng, appointed in Mar 2017, has a tenure of 7.67 years. directly owns 0.05% of the company’s shares, worth CN¥6.15M. The average tenure of the management team and the board of directors is 7.7 years and 5.2 years respectively.

Wichtige Informationen

Dan Zheng

Geschäftsführender

CN¥2.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer7.7yrs
Eigentum des Geschäftsführers0.05%
Durchschnittliche Amtszeit des Managements7.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.2yrs

Jüngste Management Updates

Recent updates

We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings

Nov 01
We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings

Investors Appear Satisfied With Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Prospects

Sep 26
Investors Appear Satisfied With Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Prospects

These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Jun 12
There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

May 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

May 21
This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Geschäftsführer

Dan Zheng (60 yo)

7.7yrs

Amtszeit

CN¥2,608,700

Vergütung

Ms. Dan Zheng serves as General Manager of Tianjin Chase Sun Pharmaceutical Co.,Ltd since March 24, 2017 and serves as its Vice Chairman since April 24, 2019. She serves as Director of Tianjin Chase Sun Ph...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Dan Zheng
GM & Vice Chairman7.7yrsCN¥2.61m0.050%
CN¥ 6.1m
Wu Jun Lan
Executive GM12.9yrsCN¥1.81m0.050%
CN¥ 6.1m
Wu Sun
Deputy GMno dataCN¥979.30kkeine Daten
Chun Xu Li
Deputy GMno dataCN¥1.11m0.022%
CN¥ 2.8m
Rui Qiang Chen
GM of Human Resource Center & Deputy GMno dataCN¥1.21m0.023%
CN¥ 2.8m
Kun Zhang
Deputy General Manager7.7yrsCN¥1.32m0.031%
CN¥ 3.8m
Xiao Zhong Lu
Deputy General Manager2.6yrsCN¥1.76mkeine Daten

7.7yrs

Durchschnittliche Betriebszugehörigkeit

49yo

Durchschnittliches Alter

Erfahrenes Management: 300026's management team is seasoned and experienced (7.7 years average tenure).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Dan Zheng
GM & Vice Chairman7.6yrsCN¥2.61m0.050%
CN¥ 6.1m
Wu Jun Lan
Executive GM5.6yrsCN¥1.81m0.050%
CN¥ 6.1m
Wu Sun
Deputy GM5.6yrsCN¥979.30kkeine Daten
Chun Xu Li
Deputy GMless than a yearCN¥1.11m0.022%
CN¥ 2.8m
Xiaoqing Yao
Chairman24.2yrsCN¥2.66m10.24%
CN¥ 1.3b
Peng Fei Tu
Independent Director4.8yrsCN¥120.00kkeine Daten
Dan Liang
Employee Representative Member of Supervisory Board & Securities Affairs Representative11.6yrsCN¥91.00kkeine Daten
Shengtian Wang
Independent Director6.9yrsCN¥120.00kkeine Daten
Tao Gong
Independent Director4.8yrsCN¥120.00kkeine Daten
Li Li
Independent Director4yrsCN¥120.00kkeine Daten
Sen Lin
Directorless than a yearkeine Datenkeine Daten
Juan Chen
Director1.3yrskeine Datenkeine Daten

5.2yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrener Vorstand: 300026's board of directors are considered experienced (5.2 years average tenure).